UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model

Clinical therapeutics, 2000-07, Vol.22 (7), p.826-833

2000

Volltextzugriff (PDF)

Evaluation of the efficacy of Olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model

Clinical therapeutics, 2001-08, Vol.23 (8), p.1272-1280

2001

Volltextzugriff (PDF)

Ocular allergic disease in the senior patient: diagnosis and management

Allergy and asthma proceedings, 2000-09, Vol.21 (5), p.277-283

Berdy, G J

2000

Volltextzugriff (PDF)

Effect of Cyclosporine 0.09% Treatment on Accuracy of Preoperative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.3679-3686

2021

Volltextzugriff (PDF)

Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study

Clinical ophthalmology (Auckland, N.Z.), 2012-01, Vol.6 (default), p.855-863

2012

Volltextzugriff (PDF)

Allergic conjunctivitis : a survey of new antihistamines

Journal of ocular pharmacology, 1991, Vol.7 (4), p.313-324

1991

Volltextzugriff (PDF)

Gastroesophageal reflux disease presenting as xerophthalmia

Journal of pediatric ophthalmology and strabismus, 2001-09, Vol.38 (5), p.315-317

2001

Volltextzugriff (PDF)

The Effects of Systemic Medication on Ocular Allergic Disease

Acta ophthalmologica Scandinavica, 2000-06, Vol.78 (230), p.26-31

Berdy, Gregg J.

2000

Volltextzugriff (PDF)

Atopic Keratoconjunctivitis (AKC)

Acta ophthalmologica Scandinavica, 1999-01, Vol.77 (228), p.7-9

Berdy, Gregg J.

1999

Volltextzugriff (PDF)

Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model

Clinical therapeutics, 2002-06, Vol.24 (6), p.918-929

2002

Volltextzugriff (PDF)

Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects

Archives of ophthalmology (1960), 1992-04, Vol.110 (4), p.528

1992

Volltextzugriff (PDF)

Once-A-Day Olopatadine Improves the Health-Related Quality-Of-Life of Allergic Conjunctivitis Patients

Journal of allergy and clinical immunology, 2007, Vol.119 (1), p.S42-S42

2007

Volltextzugriff (PDF)

Ocular Allergic Disorders and Dry Eye Disease: Associations, Diagnostic Dilemmas, and Management ( Note)

Acta ophthalmologica Scandinavica, 2000-06, Vol.78 (230), p.32-37

2000

Volltextzugriff (PDF)

Proper Retrospective Study

Journal of cataract and refractive surgery, 1989-09, Vol.15 (5), p.595-596

1989

Volltextzugriff (PDF)

Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: A pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies

Journal of ocular pharmacology and therapeutics, 2002-10, Vol.18 (5), p.475-488

2002

Volltextzugriff (PDF)

Angle closure glaucoma precipitated by aerosolized atropine

Archives of internal medicine (1960), 1991-08, Vol.151 (8), p.1658

1991

Volltextzugriff (PDF)

Angle closure glaucoma precipitated by aerosolized atropine

Archives of internal medicine (1960), 1991-08, Vol.151 (8), p.1658-1660

Berdy, G. J.

1991

Volltextzugriff (PDF)

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study

Ophthalmology (Rochester, Minn.), 2023-05, Vol.130 (5), p.516-524

2023

Volltextzugriff (PDF)

The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.3841-3849

2022

Volltextzugriff (PDF)

Molecular Characterization of At5PTase1, an Inositol Phosphatase Capable of Terminating Inositol Trisphosphate Signaling

Plant physiology (Bethesda), 2001-06, Vol.126 (2), p.801-810

2001

Volltextzugriff (PDF)

Donor, Recipient, and Operative Factors Associated With Increased Endothelial Cell Loss in the Cornea Preservation Time Study

JAMA ophthalmology, 2019-02, Vol.137 (2), p.185

2019

Volltextzugriff (PDF)

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction

Ophthalmology (Rochester, Minn.), 2023-05, Vol.130 (5), p.516-524

2023

Volltextzugriff (PDF)

Lacripep for the Treatment of Primary Sjögren-Associated Ocular Surface Disease: Results of the First-In-Human Study

Cornea, 2023-07, Vol.42 (7), p.847-857

2023

Volltextzugriff (PDF)

D451 CLINICAL ACTIVITY OF AK002, AN ANTI-SIGLEC-8 ANTIBODY, IN SEVERE ALLERGIC CONJUNCTIVITIS AND COMORBID ATOPIC DISEASES

Annals of allergy, asthma, & immunology, 2019-11, Vol.123 (5), p.S17-S17

2019

Volltextzugriff (PDF)

A Controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Prophylactic Treatment of Seasonal Allergic Conjunctivitis

American journal of ophthalmology, 1997-06, Vol.123 (6), p.791-797

1997

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(22)
Humans
(17)
Ophthalmology
(17)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Double-Blind Method
(9)
Conjunctivitis, Allergic - Drug Therapy
(8)
Female
(7)
Male
(7)
Pharmacology. Drug Treatments
(7)
Adult
(6)
Middle Aged
(6)
Aged
(5)
Anti-Allergic Agents - Therapeutic Use
(5)
Pharmacology & Pharmacy
(5)
Cornea
(4)
Dry Eye
(4)
Engineering
(4)
Engineering, Electrical & Electronic
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model

Evaluation of the efficacy of Olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model

Ocular allergic disease in the senior patient: diagnosis and management

Effect of Cyclosporine 0.09% Treatment on Accuracy of Preoperative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery

Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study

Allergic conjunctivitis : a survey of new antihistamines

Gastroesophageal reflux disease presenting as xerophthalmia

The Effects of Systemic Medication on Ocular Allergic Disease

Atopic Keratoconjunctivitis (AKC)

Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model

Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects

Once-A-Day Olopatadine Improves the Health-Related Quality-Of-Life of Allergic Conjunctivitis Patients

Ocular Allergic Disorders and Dry Eye Disease: Associations, Diagnostic Dilemmas, and Management ( Note)

Proper Retrospective Study

Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: A pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies

Angle closure glaucoma precipitated by aerosolized atropine

Angle closure glaucoma precipitated by aerosolized atropine

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study

The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye

Molecular Characterization of At5PTase1, an Inositol Phosphatase Capable of Terminating Inositol Trisphosphate Signaling

Donor, Recipient, and Operative Factors Associated With Increased Endothelial Cell Loss in the Cornea Preservation Time Study

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction

Lacripep for the Treatment of Primary Sjögren-Associated Ocular Surface Disease: Results of the First-In-Human Study

D451 CLINICAL ACTIVITY OF AK002, AN ANTI-SIGLEC-8 ANTIBODY, IN SEVERE ALLERGIC CONJUNCTIVITIS AND COMORBID ATOPIC DISEASES

A Controlled Evaluation of the Efficacy and Safety of Loteprednol Etabonate in the Prophylactic Treatment of Seasonal Allergic Conjunctivitis

Suchergebnisse filtern